Pancreatic Cancer Research

ResearcherDr Lütfi Kırdar Kartal Eğitim ve Araştırma HastanesiActive in the last 2 years

Mahmut Gümüş

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3550-9993; OpenAlex author ID A5008382382, A5030906656. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2012: 2 papers · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 4

  1. Pretreatment CONUT Score and Overall Survival in Patients with Metastatic Pancreatic Adenocarcinoma Receiving First-Line Chemotherapy: A Retrospective Cohort S… Last author DOI 10.3390/medicina62091732↗
  2. FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer. Last author DOI 10.1080/1120009x.2022.2026125↗
  3. Long term survivors with metastatic pancreatic cancer treated with gemcitabine alone or plus cisplatin: a retrospective analysis of an Anatolian Society of Med… Co-author DOI 10.7314/apjcp.2012.13.5.1841↗
  4. Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multic… Co-author PMID 22517701↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zeynep Alaca Topcu · 1 shared paper, 2026 · strength 0.39
  2. Seval Ay Ersoy · 1 shared paper, 2022 · strength 0.15
  3. Didem Taştekin · 1 shared paper, 2022 · strength 0.15
  4. Velı Berk · 2 shared papers, 2012 · strength 0.05
  5. Ali̇ İnal · 2 shared papers, 2012 · strength 0.05
  6. Fahriye Tuğba Köş · 2 shared papers, 2012 · strength 0.05
  7. Abdurrahman Işıkdoğan · 2 shared papers, 2012 · strength 0.05
  8. Nuriye Özdemir · 2 shared papers, 2012 · strength 0.05
  9. Metin Özkan · 2 shared papers, 2012 · strength 0.05
  10. Gamze Göksel Ozturk · 1 shared paper, 2012 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.